Free tool
FAERS Monitor: Ultra-Technekow V4
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017243 or its brand name (Ultra-Technekow V4, Technetium Tc-99m Sodium Pertechnetate Generator). Reports on generic versions are filed under their own applications.
Reports
628
Serious
84
13% of reports
Hospitalization
29
Death reported
11
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective271
- no adverse event209
- radioisotope scan abnormal158
- scan myocardial perfusion abnormal24
- nausea18
- headache16
- radiation overdose16
- rash15
- urticaria15
- pruritus14
- vomiting14
- product quality issue13
- pyrexia10
- diarrhoea9
- dizziness9
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 1 |
| 2007 | 10 |
| 2008 | 30 |
| 2009 | 112 |
| 2010 | 87 |
| 2011 | 40 |
| 2012 | 7 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 10 |
| 2020 | 15 |
| 2021 | 30 |
| 2022 | 47 |
| 2023 | 25 |
| 2024 | 30 |
| 2025 | 73 |
| 2026 | 104 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,531 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| radiation overdoseSignal | 16 | 14115.7 | 7912.4 | 149,132 |
| radioisotope scan abnormalSignal | 158 | 9648.3 | 8232.2 | 1,176,065 |
| scan myocardial perfusion abnormalSignal | 24 | 6189.2 | 4032.7 | 120,182 |
| no adverse eventSignal | 209 | 38.7 | 34.6 | 7,691 |
| drug ineffectiveSignal | 271 | 6.9 | 6.3 | 1,449 |
| product quality issueSignal | 13 | 3.2 | 1.9 | 18 |
| urticariaSignal | 15 | 3.0 | 1.8 | 18 |
| pruritus | 14 | 1.2 | 0.7 | 0 |
| rash | 15 | 1.2 | 0.7 | 0 |
| vomiting | 14 | 1.0 | 0.6 | 0 |
| pyrexia | 10 | 1.0 | 0.5 | 0 |
| headache | 16 | 0.9 | 0.5 | 0 |
| nausea | 18 | 0.8 | 0.5 | 1 |
| dizziness | 9 | 0.6 | 0.3 | 2 |
| diarrhoea | 9 | 0.5 | 0.2 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.